Tramadol Hydrochloride Compounded Oral Suspension
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Tramadol Hydrochloride Compounded Oral Suspension contains NLT 90.0% and NMT 110.0% of the labeled amount of tramadol hydrochloride (C₁₆H₂₅NO₂ · HCl).
Prepare Tramadol Hydrochloride Compounded Oral Suspension 5 mg/mL as follows (see Pharmaceutical Compounding-Nonsterile Preparations 〈795〉).
| Tramadol Hydrochloride tabletsᵃ equivalent to | 500 mg of tramadol hydrochloride |
| Vehicle: a 1:1 mixture of Ora-Sweetᵇ (sugar-free) and Ora-Plusᵇ, a sufficient quantity to make | 100 mL |
ᵃ Ultram 50-mg tablets, Ortho-McNeil Pharmaceutical, Inc., Raritan, NJ.
ᵇ Paddock Laboratories, Minneapolis, MN.
Calculate the required quantity of each ingredient for the total amount to be prepared. Place the required number of Tramadol Hydrochloride tablets in a suitable mortar, and comminute to a fine powder. Add the Vehicle in small portions, and triturate to make a smooth paste. Add increasing volumes of the Vehicle to make a tramadol hydrochloride liquid that is pourable. Transfer the contents of the mortar, stepwise and quantitatively, to a calibrated bottle. Add enough of the Vehicle to bring to final volume, and mix well.
2 ASSAY
2.1 Procedure
Solution A: 20 mM of phosphoric acid and 4 g/L of sodium 1-hexane sulfonate
Mobile phase: Acetonitrile and Solution A (50:50). Filter and degas.
Diluent: Acetonitrile and water (50:50)
Standard solution: 0.25 mg/mL of USP Tramadol Hydrochloride RS in Diluent
Sample solution: Shake thoroughly by hand each bottle of Oral Suspension. Prepare 0.25 mg/mL of tramadol hydrochloride from Oral Suspension and Diluent, and centrifuge.
Chromatographic system
- (See Chromatography 〈621〉, System Suitability.)
- Mode: LC
- Detector: UV 275 nm
- Column: 4.6-mm × 25-cm; 5-µm packing L1
- Column temperature: 30°
- Flow rate: 1.0 mL/min
- Injection volume: 5 µL
System suitability
- Sample: Standard solution
- [Note-The retention time for tramadol hydrochloride is about 6 min.]
- Suitability requirements
- Relative standard deviation: NMT 2.0% for replicate injections
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of tramadol hydrochloride (C₁₆H₂₅NO₂ · HCl) in the portion of Oral Suspension taken:
Result = (rᵤ/rₛ) × (Cₛ/Cᵤ) × 100
rᵤ = peak response from the Sample solution
rₛ = peak response from the Standard solution
Cₛ = concentration of USP Tramadol Hydrochloride RS in the Standard solution (mg/mL)
Cᵤ = nominal concentration of tramadol hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
3 SPECIFIC TESTS
pH 〈791〉: 3.8–4.8
4 ADDITIONAL REQUIREMENTS
Packaging and Storage: Package in tight, light-resistant containers. Store in a refrigerator or at controlled room temperature.
Beyond-Use Date: NMT 90 days after the date on which it was compounded when stored in a refrigerator or controlled room temperature
Labeling: Label it to indicate that it is to be well shaken before use, and to state the Beyond-Use Date.
USP Reference Standards 〈11〉
USP Tramadol Hydrochloride RS

